1. FDA, Orphan Designation of Cysteamine Hydrochloride for the Treatment of Cystinosis Treatment of Corneal Cystine Crystal Accumulation in Cystinosis Patients, 1997 (accessed March, 2016).
2. EMA, EMEA/COMP/552795/2014 – Public Summary of Opinion on Orphan Designation Cysteamine Hydrochloride for the Treatment of Cystinosis (EU/3/14/1341), 2014 (accessed March, 2016).
3. Cystinosis;Nesterova,2014
4. Treatment of corneal cystine crystal accumulation in patients with cystinosis;Shams;Clin. Ophthalmol. (Auckland, N.Z.),2014
5. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis;Labbé;Ophthalmology,2009